Annual Total Expenses
$18.30 M
-$1.66 M-8.34%
31 December 2023
Summary:
Enveric Biosciences annual total expenses is currently $18.30 million, with the most recent change of -$1.66 million (-8.34%) on 31 December 2023. During the last 3 years, it has fallen by -$8.77 million (-32.41%). ENVB annual total expenses is now -69.55% below its all-time high of $60.08 million, reached on 31 December 2017.ENVB Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$2.08 M
+$185.30 K+9.76%
30 September 2024
Summary:
Enveric Biosciences quarterly total expenses is currently $2.08 million, with the most recent change of +$185.30 thousand (+9.76%) on 30 September 2024. Over the past year, it has dropped by -$2.15 million (-50.78%). ENVB quarterly total expenses is now -90.67% below its all-time high of $22.33 million, reached on 31 December 1996.ENVB Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENVB Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -50.8% |
| 3 y3 years | -32.4% | -84.1% |
| 5 y5 years | -60.4% | -81.2% |
ENVB Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.4% | at low | -84.1% | +9.8% |
| 5 y | 5 years | -60.4% | +185.0% | -84.1% | +325.3% |
| alltime | all time | -69.5% | >+9999.0% | -90.7% | +277.1% |
Enveric Biosciences Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.08 M(+9.8%) |
| June 2024 | - | $1.90 M(-23.4%) |
| Mar 2024 | - | $2.48 M(-41.5%) |
| Dec 2023 | $18.30 M(-8.3%) | $4.23 M(+22.7%) |
| Sept 2023 | - | $3.45 M(-40.1%) |
| June 2023 | - | $5.75 M(+18.4%) |
| Mar 2023 | - | $4.86 M(+1.2%) |
| Dec 2022 | $19.96 M(-26.3%) | $4.80 M(-15.1%) |
| Sept 2022 | - | $5.66 M(+20.2%) |
| June 2022 | - | $4.71 M(-1.9%) |
| Mar 2022 | - | $4.80 M(-63.5%) |
| Dec 2021 | $27.07 M(+321.7%) | $13.13 M(+273.2%) |
| Sept 2021 | - | $3.52 M(+4.6%) |
| June 2021 | - | $3.36 M(-52.4%) |
| Mar 2021 | - | $7.06 M(+63.3%) |
| Dec 2020 | $6.42 M(-86.1%) | $4.33 M(+783.1%) |
| Sept 2020 | - | $489.80 K(-36.2%) |
| June 2020 | - | $767.50 K(-93.2%) |
| Mar 2020 | - | $11.21 M(+1.4%) |
| Dec 2019 | $46.24 M(-3.1%) | $11.05 M(+3.1%) |
| Sept 2019 | - | $10.71 M(-14.2%) |
| June 2019 | - | $12.49 M(+4.2%) |
| Mar 2019 | - | $11.98 M(+2.0%) |
| Dec 2018 | $47.71 M(-20.6%) | $11.75 M(+2.0%) |
| Sept 2018 | - | $11.52 M(-4.1%) |
| June 2018 | - | $12.02 M(-3.2%) |
| Mar 2018 | - | $12.42 M(-18.6%) |
| Dec 2017 | $60.08 M(+50.4%) | $15.25 M(-7.4%) |
| Sept 2017 | - | $16.47 M(+5.6%) |
| June 2017 | - | $15.60 M(+22.2%) |
| Mar 2017 | - | $12.76 M(-12.6%) |
| Dec 2016 | $39.94 M(+105.9%) | $14.60 M(+41.3%) |
| Sept 2016 | - | $10.33 M(+40.0%) |
| June 2016 | - | $7.38 M(-3.1%) |
| Mar 2016 | - | $7.62 M(+68.2%) |
| Dec 2015 | $19.40 M(>+9900.0%) | - |
| Sept 2015 | - | $4.53 M(+31.5%) |
| June 2015 | - | $3.45 M(>+9900.0%) |
| Mar 2015 | - | $2300.00(-77.9%) |
| Dec 2014 | $32.80 K(+20.6%) | $10.40 K(+235.5%) |
| Sept 2014 | - | $3100.00(-73.5%) |
| June 2014 | - | $11.70 K(+53.9%) |
| Mar 2014 | - | $7600.00(-46.1%) |
| Dec 2013 | $27.20 K(+19.8%) | $14.10 K(+206.5%) |
| Sept 2013 | - | $4600.00(+17.9%) |
| June 2013 | - | $3900.00(-17.0%) |
| Mar 2013 | - | $4700.00(-53.0%) |
| Dec 2012 | $22.70 K(-27.7%) | $10.00 K(+117.4%) |
| Sept 2012 | - | $4600.00(+12.2%) |
| June 2012 | - | $4100.00(+2.5%) |
| Mar 2012 | - | $4000.00(-69.2%) |
| Dec 2011 | $31.40 K(-12.5%) | $13.00 K(+251.4%) |
| Sept 2011 | - | $3700.00(+2.8%) |
| June 2011 | - | $3600.00(-67.6%) |
| Mar 2011 | - | $11.10 K(-2.6%) |
| Dec 2010 | $35.90 K | $11.40 K(+103.6%) |
| Sept 2010 | - | $5600.00(+24.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $4500.00(-68.8%) |
| Mar 2010 | - | $14.40 K(-30.8%) |
| Dec 2009 | $55.60 K(-63.3%) | $20.80 K(+362.2%) |
| Sept 2009 | - | $4500.00(-66.9%) |
| June 2009 | - | $13.60 K(-18.6%) |
| Mar 2009 | - | $16.70 K(-52.3%) |
| Dec 2008 | $151.40 K(-28.0%) | $35.00 K(+354.5%) |
| Sept 2008 | - | $7700.00(-79.7%) |
| June 2008 | - | $38.00 K(-46.3%) |
| Mar 2008 | - | $70.70 K(-131.8%) |
| Dec 2007 | $210.40 K(-69.4%) | -$222.10 K(-348.7%) |
| Sept 2007 | - | $89.30 K(-58.3%) |
| June 2007 | - | $214.00 K(+66.4%) |
| Mar 2007 | - | $128.60 K(-1.2%) |
| Dec 2006 | $686.70 K(-46.5%) | $130.20 K(+0.9%) |
| Sept 2006 | - | $129.00 K(-15.6%) |
| June 2006 | - | $152.90 K(-44.3%) |
| Mar 2006 | - | $274.70 K(-21.6%) |
| Dec 2005 | $1.28 M(+2.0%) | $350.30 K(+48.0%) |
| Sept 2005 | - | $236.70 K(-36.4%) |
| June 2005 | - | $372.20 K(+15.0%) |
| Mar 2005 | - | $323.60 K(-0.6%) |
| Dec 2004 | $1.26 M(-28.3%) | $325.70 K(+13.6%) |
| Sept 2004 | - | $286.70 K(-18.7%) |
| June 2004 | - | $352.50 K(+20.4%) |
| Mar 2004 | - | $292.80 K(-34.2%) |
| Dec 2003 | $1.75 M(-4.8%) | $445.20 K(+0.2%) |
| Sept 2003 | - | $444.10 K(-3.5%) |
| June 2003 | - | $460.30 K(+14.1%) |
| Mar 2003 | - | $403.50 K(-17.1%) |
| Dec 2002 | $1.84 M(-4.1%) | $486.90 K(+3.7%) |
| Sept 2002 | - | $469.70 K(+0.4%) |
| June 2002 | - | $467.90 K(+12.1%) |
| Mar 2002 | - | $417.50 K(-0.9%) |
| Dec 2001 | $1.92 M(+4.1%) | $421.30 K(-12.5%) |
| Sept 2001 | - | $481.70 K(-18.0%) |
| June 2001 | - | $587.10 K(+36.7%) |
| Mar 2001 | - | $429.40 K(-26.5%) |
| Dec 2000 | $1.84 M(+53.0%) | $583.90 K(+10.5%) |
| Sept 2000 | - | $528.20 K(+27.5%) |
| June 2000 | - | $414.20 K(+30.5%) |
| Mar 2000 | - | $317.40 K(-127.0%) |
| Dec 1999 | $1.20 M(-66.8%) | - |
| Dec 1998 | $3.62 M(-51.5%) | -$1.18 M(-169.2%) |
| Sept 1998 | - | $1.70 M(-5.6%) |
| June 1998 | - | $1.80 M(+12.5%) |
| Mar 1998 | - | $1.60 M(-40.0%) |
| Dec 1997 | $7.47 M(-72.6%) | $2.67 M(+56.9%) |
| Sept 1997 | - | $1.70 M(0.0%) |
| June 1997 | - | $1.70 M(+6.3%) |
| Mar 1997 | - | $1.60 M(-92.8%) |
| Dec 1996 | $27.23 M(+491.9%) | $22.33 M(+1295.5%) |
| Sept 1996 | - | $1.60 M(-23.8%) |
| June 1996 | - | $2.10 M(+75.0%) |
| Mar 1996 | - | $1.20 M |
| Dec 1995 | $4.60 M(+253.8%) | - |
| Dec 1994 | $1.30 M(-35.0%) | - |
| Aug 1994 | $2.00 M | - |
FAQ
- What is Enveric Biosciences annual total expenses?
- What is the all time high annual total expenses for Enveric Biosciences?
- What is Enveric Biosciences quarterly total expenses?
- What is the all time high quarterly total expenses for Enveric Biosciences?
- What is Enveric Biosciences quarterly total expenses year-on-year change?
What is Enveric Biosciences annual total expenses?
The current annual total expenses of ENVB is $18.30 M
What is the all time high annual total expenses for Enveric Biosciences?
Enveric Biosciences all-time high annual total expenses is $60.08 M
What is Enveric Biosciences quarterly total expenses?
The current quarterly total expenses of ENVB is $2.08 M
What is the all time high quarterly total expenses for Enveric Biosciences?
Enveric Biosciences all-time high quarterly total expenses is $22.33 M
What is Enveric Biosciences quarterly total expenses year-on-year change?
Over the past year, ENVB quarterly total expenses has changed by -$2.15 M (-50.78%)